BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 20857294)

  • 21. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection.
    English L; Chemali M; Duron J; Rondeau C; Laplante A; Gingras D; Alexander D; Leib D; Norbury C; Lippé R; Desjardins M
    Nat Immunol; 2009 May; 10(5):480-7. PubMed ID: 19305394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autophagy Proteins in Viral Exocytosis and Anti-Viral Immune Responses.
    Münz C
    Viruses; 2017 Oct; 9(10):. PubMed ID: 28976939
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of viruses on the ability to present antigens via the major histocompatibility complex.
    Peters VB; Sperber KE
    Microbes Infect; 1999 Apr; 1(4):335-45. PubMed ID: 10602667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.
    Schmid D; Pypaert M; Münz C
    Immunity; 2007 Jan; 26(1):79-92. PubMed ID: 17182262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune surveillance via self digestion.
    Schmid D; Münz C
    Autophagy; 2007; 3(2):133-5. PubMed ID: 17204851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections.
    Towne CF; York IA; Neijssen J; Karow ML; Murphy AJ; Valenzuela DM; Yancopoulos GD; Neefjes JJ; Rock KL
    J Immunol; 2008 Feb; 180(3):1704-12. PubMed ID: 18209067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses.
    You L; Mao L; Wei J; Jin S; Yang C; Liu H; Zhu L; Qian W
    J Hematol Oncol; 2017 Oct; 10(1):165. PubMed ID: 29058602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATGs help MHC class II, but inhibit MHC class I antigen presentation.
    Loi M; Gannagé M; Münz C
    Autophagy; 2016 Sep; 12(9):1681-2. PubMed ID: 27439741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytosol to lysosome transport of intracellular antigens during immune surveillance.
    Crotzer VL; Blum JS
    Traffic; 2008 Jan; 9(1):10-6. PubMed ID: 17916226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
    Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
    Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathways of antigen processing and presentation.
    Watts C; Powis S
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
    Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
    Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy in MHC class II presentation of endogenous antigens.
    Gannagé M; Münz C
    Curr Top Microbiol Immunol; 2009; 335():123-40. PubMed ID: 19802563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing immunity through autophagy.
    Münz C
    Annu Rev Immunol; 2009; 27():423-49. PubMed ID: 19105657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen Processing for MHC Class II Presentation via Autophagy.
    Münz C
    Front Immunol; 2012; 3():9. PubMed ID: 22566895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production.
    McMenamin C; Holt PG
    J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.